Published in Nat Biotechnol on May 30, 2010
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res (2012) 2.91
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res (2012) 2.51
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods (2010) 2.15
Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun (2012) 1.70
Soft substrates promote homogeneous self-renewal of embryonic stem cells via downregulating cell-matrix tractions. PLoS One (2010) 1.67
Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano (2012) 1.47
An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat Commun (2011) 1.45
Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods (2011) 1.42
Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials (2010) 1.42
Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells (2013) 1.42
The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials (2010) 1.40
Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells (2012) 1.40
Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A (2011) 1.25
Mechanics regulates fate decisions of human embryonic stem cells. PLoS One (2012) 1.24
Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc (2011) 1.21
Glycosaminoglycan-binding hydrogels enable mechanical control of human pluripotent stem cell self-renewal. ACS Nano (2012) 1.20
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther (2011) 1.12
Fabrication of synthetic polymer coatings and their use in feeder-free culture of human embryonic stem cells. Nat Protoc (2011) 1.12
Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials (2011) 1.11
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell (2014) 1.10
Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications. PLoS One (2012) 1.03
Developing defined culture systems for human pluripotent stem cells. Regen Med (2011) 1.01
Rethinking in vitro embryo culture: new developments in culture platforms and potential to improve assisted reproductive technologies. Biol Reprod (2012) 1.00
A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells. Nat Commun (2013) 0.98
Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon. Nat Protoc (2013) 0.97
Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc (2012) 0.97
Signals from the surface modulate differentiation of human pluripotent stem cells through glycosaminoglycans and integrins. Proc Natl Acad Sci U S A (2014) 0.95
Non-colony type monolayer culture of human embryonic stem cells. Stem Cell Res (2012) 0.94
Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells. Biomaterials (2012) 0.94
Application of biomaterials to advance induced pluripotent stem cell research and therapy. EMBO J (2015) 0.90
Monolayer culturing and cloning of human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically defined conditions. Nat Protoc (2014) 0.90
Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels. Biomaterials (2013) 0.89
Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol (2015) 0.89
Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine. ACS Nano (2013) 0.87
Defining synthetic surfaces for human pluripotent stem cell culture. Cell Regen (Lond) (2013) 0.87
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med (2012) 0.86
Delivery of proteases in aqueous two-phase systems enables direct purification of stem cell colonies from feeder cell co-cultures for differentiation into functional cardiomyocytes. Adv Healthc Mater (2013) 0.86
Exploiting bacterial peptide display technology to engineer biomaterials for neural stem cell culture. Biomaterials (2010) 0.85
Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol (2013) 0.85
Feeder cells support the culture of induced pluripotent stem cells even after chemical fixation. PLoS One (2012) 0.85
Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A (2013) 0.84
On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology. Biomaterials (2015) 0.84
The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells. Stem Cells Dev (2013) 0.84
Optimizing stem cell culture. J Cell Biochem (2010) 0.84
Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges. Stem Cell Rev (2015) 0.83
α-5 Laminin Synthesized by Human Pluripotent Stem Cells Promotes Self-Renewal. Stem Cell Reports (2015) 0.83
Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation. Adv Mater (2015) 0.83
Microarrayed Materials for Stem Cells. Mater Today (Kidlington) (2012) 0.83
Comparison of several attachment methods for human iPS, embryonic and adipose-derived stem cells for tissue engineering. J Tissue Eng Regen Med (2012) 0.81
Scalable pluripotent stem cell culture. Nat Biotechnol (2010) 0.81
Enhancement of the propagation of human embryonic stem cells by modifications in the gel architecture of PMEDSAH polymer coatings. Biomaterials (2014) 0.80
Characterization of the interface between adsorbed fibronectin and human embryonic stem cells. J R Soc Interface (2013) 0.80
PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering. Int J Nanomedicine (2011) 0.80
Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells. PLoS One (2015) 0.79
Silica bioreplication preserves three-dimensional spheroid structures of human pluripotent stem cells and HepG2 cells. Sci Rep (2015) 0.79
Long-term xeno-free culture of human pluripotent stem cells on hydrogels with optimal elasticity. Sci Rep (2015) 0.79
Mucin-Inspired Thermoresponsive Synthetic Hydrogels Induce Stasis in Human Pluripotent Stem Cells and Human Embryos. ACS Cent Sci (2016) 0.79
A synthetic peptide-acrylate surface for production of insulin-producing cells from human embryonic stem cells. Stem Cells Dev (2013) 0.79
Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013. Ann Biomed Eng (2013) 0.79
Advances in cell culture: anchorage dependence. Philos Trans R Soc Lond B Biol Sci (2015) 0.79
Matrix revolutions: a trinity of defined substrates for long-term expansion of human ESCs. Cell Stem Cell (2010) 0.79
Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces. Langmuir (2013) 0.79
Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J (2014) 0.78
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state. PLoS One (2013) 0.78
Development of a simple, repeatable, and cost-effective extracellular matrix for long-term xeno-free and feeder-free self-renewal of human pluripotent stem cells. Histochem Cell Biol (2013) 0.78
Development of a human extracellular matrix for applications related with stem cells and tissue engineering. Stem Cell Rev (2012) 0.78
Advances in culture and manipulation of human pluripotent stem cells. J Dent Res (2013) 0.78
A spatially and chemically defined platform for the uniform growth of human pluripotent stem cells. Mater Sci Eng C Mater Biol Appl (2012) 0.77
Engineering biomaterials for feeder-free maintenance of human pluripotent stem cells. Int J Stem Cells (2012) 0.77
Molecular recognition enables nanosubstrate-mediated delivery of gene-encapsulated nanoparticles with high efficiency. ACS Nano (2014) 0.77
Substrates and supplements for hESCs: a critical review. J Assist Reprod Genet (2013) 0.76
Biomaterial strategies for stem cell maintenance during in vitro expansion. Tissue Eng Part B Rev (2013) 0.76
Defined substrates for pluripotent stem cells: are we there yet? Nat Methods (2010) 0.76
Biomaterials for pluripotent stem cell engineering: From fate determination to vascularization. J Mater Chem B Mater Biol Med (2016) 0.75
Substrates for clinical applicability of stem cells. World J Stem Cells (2015) 0.75
Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture. Nat Commun (2016) 0.75
Efficient Adhesion Culture of Human Pluripotent Stem Cells Using Laminin Fragments in an Uncoated Manner. Sci Rep (2017) 0.75
Nanoengineered Platforms to Guide Pluripotent Stem Cell Fate. J Nanomed Nanotechnol (2014) 0.75
Concise review: animal substance-free human embryonic stem cells aiming at clinical applications. Stem Cells Transl Med (2014) 0.75
An in vitro culture system that supports robust expansion and maintenance of in vivo engraftment capabilities for myogenic progenitor cells from adult mice. Biores Open Access (2014) 0.75
Derivation and long-term culture of transgene-free human induced pluripotent stem cells on synthetic substrates. Stem Cells Transl Med (2014) 0.75
Ethanol Inactivated Mouse Embryonic Fibroblasts Maintain the Self-Renew and Proliferation of Human Embryonic Stem Cells. PLoS One (2015) 0.75
Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. J Mater Chem B Mater Biol Med (2016) 0.75
Xeno-free culture of human pluripotent stem cells on oligopeptide-grafted hydrogels with various molecular designs. Sci Rep (2017) 0.75
A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays. Biomaterials (2015) 0.75
Peptide Conjugation to a Polymer Coating via Native Chemical Ligation of Azlactones for Cell Culture. Biomacromolecules (2016) 0.75
Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells. Sci Rep (2016) 0.75
Polymer brush: The promising grafting approach to scaffolds for tissue engineering. BMB Rep (2016) 0.75
Comparison of static culture, micro-vibration culture, and micro-vibration culture with co-culture in poor ovarian responders. Clin Exp Reprod Med (2016) 0.75
Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem Cells Int (2016) 0.75
Effects of the polymeric niche on neural stem cell characteristics during primary culturing. J Mater Sci Mater Med (2014) 0.75
Integrated zwitterionic conjugated poly(carboxybetaine thiophene) as a new biomaterial platform. Chem Sci (2014) 0.75
Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol (2001) 11.53
Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol (2006) 8.28
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells (2008) 3.33
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood (2007) 3.05
Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem Biol (2007) 2.08
Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A (2006) 1.97
Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol (2006) 1.61
Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology. Stem Cells Dev (2009) 1.46
Comparison of biomaterials and extracellular matrices as a culture platform for multiple, independently derived human embryonic stem cell lines. Tissue Eng Part A (2009) 1.37
Multiplexed staining of live human embryonic stem cells for flow cytometric analysis of pluripotency markers. Stem Cells Dev (2009) 1.01
MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol (2010) 26.41
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet (2012) 6.15
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci (2007) 4.93
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest (2011) 4.43
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Physical approaches to biomaterial design. Nat Mater (2009) 4.01
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes. Am J Hum Genet (2010) 3.47
Ultrastrong and stiff layered polymer nanocomposites. Science (2007) 3.40
Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. J Cell Biol (2004) 3.00
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials (2005) 2.66
Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet (2010) 2.66
Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med (2009) 2.51
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Multicompartmental microcylinders. Angew Chem Int Ed Engl (2009) 2.19
LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet (2007) 2.13
Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol (2009) 2.06
Ultrasmall implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces. Nat Mater (2012) 1.93
Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials (2006) 1.88
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
Biphasic Janus particles with nanoscale anisotropy. Nat Mater (2005) 1.86
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J (2005) 1.79
Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem (2007) 1.70
VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res (2006) 1.63
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun (2013) 1.61
Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol (2010) 1.61
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells (2008) 1.58
In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res (2003) 1.57
Fabrication of discontinuous surface patterns within microfluidic channels using photodefinable vapor-based polymer coatings. Anal Chem (2005) 1.54
Fat grafting for thermal injury: current state and future directions. J Burn Care Res (2013) 1.51
Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood (2007) 1.48
Passively driven integrated microfluidic system for separation of motile sperm. Anal Chem (2003) 1.48
Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano (2012) 1.47
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature (2010) 1.47
Characterization and resolution of evaporation-mediated osmolality shifts that constrain microfluidic cell culture in poly(dimethylsiloxane) devices. Anal Chem (2007) 1.45
iSNO-PseAAC: predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One (2013) 1.45
Erythropoietin couples hematopoiesis with bone formation. PLoS One (2010) 1.44
Processed total motile sperm count correlates with pregnancy outcome after intrauterine insemination. Urology (2002) 1.43
A transgenic animal model resembling amelogenesis imperfecta related to ameloblastin overexpression. J Biol Chem (2003) 1.42
Removal of heavy metals from aqueous solution by carbon nanotubes: adsorption equilibrium and kinetics. J Environ Sci (China) (2004) 1.41
Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng (2003) 1.39
Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivo. Stem Cells Dev (2010) 1.38
Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci U S A (2009) 1.38
Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev (2009) 1.38
Smad4 is required for maintaining normal murine postnatal bone homeostasis. J Cell Sci (2007) 1.37
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis (2009) 1.36
Microfluidic hydrodynamic cellular patterning for systematic formation of co-culture spheroids. Integr Biol (Camb) (2009) 1.33
Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis (2003) 1.30
Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng (2002) 1.29
Physical aspects of cell culture substrates: topography, roughness, and elasticity. Small (2011) 1.26
Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells. Stem Cells (2006) 1.26
The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs (2008) 1.24
Mechanics regulates fate decisions of human embryonic stem cells. PLoS One (2012) 1.24
Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells (2010) 1.24
Glutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies. J Neurosci (2008) 1.20
Sperm DNA damage in male infertility: etiologies, assays, and outcomes. J Assist Reprod Genet (2009) 1.18
Predicting outcomes after traumatic brain injury: the development and validation of prognostic models based on admission characteristics. J Trauma Acute Care Surg (2012) 1.15
Growth of single-crystalline Ni and Co nanowires via electrochemical deposition and their magnetic properties. J Phys Chem B (2005) 1.13
Fabrication of synthetic polymer coatings and their use in feeder-free culture of human embryonic stem cells. Nat Protoc (2011) 1.12
Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem (2012) 1.11
Coupled global and targeted proteomics of human embryonic stem cells during induced differentiation. Mol Cell Proteomics (2008) 1.11
An in vivo model to study and manipulate the hematopoietic stem cell niche. Blood (2010) 1.11
Reactive polymer coatings that "Click". Angew Chem Int Ed Engl (2006) 1.11
Adsorption thermodynamic, kinetic and desorption studies of Pb2+ on carbon nanotubes. Water Res (2004) 1.11
Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo. Stem Cells Dev (2014) 1.10
Structural, biochemical, and expression analysis of two distinct insulin-like growth factor I receptors and their ligands in zebrafish. Endocrinology (2002) 1.09
Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology (2007) 1.09
Evidence for altered Wnt signaling in psoriatic skin. J Invest Dermatol (2010) 1.08
HnRNP U mediates the long-range regulation of Shh expression during limb development. Hum Mol Genet (2009) 1.08
Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res (2013) 1.08
Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am J Pathol (2011) 1.07
Proteomics and genetics of dental enamel. Cells Tissues Organs (2005) 1.07
Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng (2004) 1.07
Solventless adhesive bonding using reactive polymer coatings. Anal Chem (2008) 1.06
The insulation performance of reactive parylene films in implantable electronic devices. Biomaterials (2009) 1.06
Human very small embryonic-like cells generate skeletal structures, in vivo. Stem Cells Dev (2012) 1.05
The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A (2010) 1.05
An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun (2009) 1.05
Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells (2009) 1.04
Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity. Proc Natl Acad Sci U S A (2012) 1.04
Burn injury enhances bone formation in heterotopic ossification model. Ann Surg (2014) 1.03
Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin. Genome Biol (2015) 1.03
Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther (2004) 1.02
Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. J Biomed Mater Res (2002) 1.02
IVF within microfluidic channels requires lower total numbers and lower concentrations of sperm. Hum Reprod (2005) 1.01
Single-crystalline MFe(2)O(4) nanotubes/nanorings synthesized by thermal transformation process for biological applications. ACS Nano (2009) 1.01
Adenosine triphosphate hydrolysis reduces neutrophil infiltration and necrosis in partial-thickness scald burns in mice. J Burn Care Res (2014) 1.01
Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med (2008) 1.01
Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials (2005) 1.01
TBK1 regulates prostate cancer dormancy through mTOR inhibition. Neoplasia (2013) 1.01